In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Example Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Puppies Assisting Wounded 
Servicemembers Act of 2017'' or the ``PAWS Act of 2017''.

SEC. 2. FINDINGS.

    Congress makes the following findings:
            (1) According to the analysis of veteran suicide published 
        by the Department of Veterans Affairs in August 2016 and titled 
        ``Suicide Among Veterans and Other Americans''--
                    (A) an average of 20 veterans died by suicide each 
                day in 2014;
                    (B) mental health disorders, including major 
                depression and other mood disorders, have been 
                associated with increased risk for suicide;
                    (C) since 2001, the proportion of users of the 
                Veterans Health Administration with mental health 
                conditions or substance use disorders has increased 
                from approximately 27 percent in 2001 to more than 40 
                percent in 2014; and
                    (D) overall, suicide rates are highest among 
                patients with mental health and substance use disorder 
                diagnoses who are in treatment and lower among those 
                who received a mental health diagnoses but were not at 
                risk enough to require enhanced care from a mental 
                health provider.
            (2) The Department of Veterans Affairs must be more 
        effective in its approach to reducing the burden of veteran 
        suicide connected to mental health disorders, including post-
        traumatic stress disorder, and a pilot program and study to 
        assess the benefits of pairing service dogs with veterans 
        suffering from mental health disorders would allow the 
        Department to better determine the efficacy of using service 
        dogs as a nontraditional therapy to ensure the well-being of 
        veterans.
            (3) Pairing a service dog with a veteran costs 
        approximately $25,000, including with respect to training of 
        the service dog as well as training of the veteran with the 
        service dog.

SEC. 3. DEPARTMENT OF VETERANS AFFAIRS PILOT PROGRAM TO PROVIDE GRANTS 
              FOR THE PROVISION OF SERVICE DOGS TO CERTAIN VETERANS 
              WITH SEVERE POST-TRAUMATIC STRESS DISORDER.

    (a) Grants.--The Secretary of Veterans Affairs shall carry out a 
pilot program under which the Secretary provides a $25,000 grant to an 
eligible organization for each veteran referred to that organization 
for a service dog pairing.
    (b) Benefits Provided.--
            (1) In general.--An organization that receives a grant 
        under subsection (a) shall provide the following for each 
        service dog and veteran participating in the pilot program:
                    (A) Coverage of a commercially available veterinary 
                health insurance policy to maintain the health of the 
                dog and keep the dog functioning in the prescribed role 
                for the life of the dog.
                    (B) Hardware, or repairs or replacements for 
                hardware, that are clinically determined to be required 
                by the dog to perform the tasks necessary to assist the 
                veteran with the diagnosed disorder of the veteran.
                    (C) Payments for travel expenses for the veteran to 
                obtain the dog, calculated in the same manner as 
                similar travel expenses provided pursuant to section 
                111 of title 38, United States Code.
            (2) Other travel expenses.--If a veteran is required to 
        replace a service dog provided pursuant to a grant under this 
        section, the Secretary shall pay for the travel expenses 
        described in paragraph (1)(C) required to obtain a new service 
        dog pursuant to subsection (c)(3), regardless of any other 
        benefits the veteran is receiving for the first service dog 
        under this section.
    (c) Eligible Organizations.--To be eligible to receive a grant 
under this section, an organization shall--
            (1) be a nonprofit organization that provides trained 
        service dogs--
                    (A) that--
                            (i) is certified by Assistance Dogs 
                        International;
                            (ii) on average, provides one-on-one 
                        training for each service dog and recipient for 
                        30 hours or more over 90 days or more;
                            (iii) provides a wellness verification from 
                        a licensed veterinarian for each service dog;
                            (iv) provides an in-house residential 
                        facility, or other accommodations nearby, in 
                        which service dog recipients stay for a minimum 
                        of 10 days while receiving at least 30 hours of 
                        training with their new service dog;
                            (v) ensures all service dogs pass the 
                        American Kennel Club Community Canine test and 
                        the ADI Public Access Test prior to permanent 
                        placement with a recipient; and
                            (vi) provides follow-up support service for 
                        the life of the service dog, to include a 
                        contact plan between the veteran and 
                        organization to allow--
                                    (I) the veteran to reach out for 
                                and receive adequate help with the 
                                service dog; and
                                    (II) the organization to 
                                communicate with the veteran to ensure 
                                that the service dog is being properly 
                                cared for; or
                    (B) that meets the Association of Service Dog 
                Providers for Military Veterans Service Dog Agency 
                Standards that cater to the unique needs of veterans 
                with post-traumatic stress disorder;
            (2) agree to cover all costs in excess of the grant amount 
        to guarantee the benefits listed under subsection (b)(1);
            (3) agree to reaccept or replace the service dog the 
        organization provided to the veteran, if necessary, as 
        determined by the organization and the veteran; and
            (4) submit to the Secretary an application containing such 
        information, certification, and assurances as the Secretary may 
        require.
    (d) Eligible Veterans.--
            (1) In general.--The Secretary of Veterans Affairs shall 
        review and approve veterans eligible to participate under this 
        section and shall refer approved veterans to eligible 
        organizations. The period beginning on the date on which a 
        veteran applies to participate under this section and the date 
        on which the Secretary makes an approval determination may not 
        exceed 90 days.
            (2) Initial eligibility.--For purposes of this section, an 
        eligible veteran is a veteran who is enrolled in the patient 
        enrollment system of the Department of Veterans Affairs under 
        section 1705 of title 38, United States Code, and--
                    (A) has been treated and has completed an 
                established evidence-based treatment for post-traumatic 
                stress disorder yet remains diagnosed with post-
                traumatic stress disorder by a qualified health care 
                provider as rated on the post-traumatic stress disorder 
                checklist (PCL-5);
                    (B) the health care provider or clinical team of 
                the Department of Veterans Affairs that is treating the 
                veteran for such disorder determines based upon medical 
                judgment that the veteran may potentially benefit from 
                a service dog; and
                    (C) agrees to successfully complete training 
                provided by an eligible organization pursuant to 
                subsection (c).
            (3) Ongoing eligibility.--To remain eligible to participate 
        in the pilot program, a veteran shall see the health care 
        provider or clinical team of the Department of Veterans Affairs 
        treating the veteran for such a disorder at least every six 
        months to determine, based on a clinical evaluation of 
        efficacy, whether the veteran continues to benefit from a 
        service dog.
            (4) Other cases.--If at any point, the veteran is no longer 
        able or willing to care for the service dog, the organization 
        that provided the service dog and the veteran shall determine 
        the appropriate recourse to ensure the safety of both the 
        veteran and the service dog.
    (e) Relationship to Department of Veterans Affairs Benefits.--The 
provision of a service dog to a veteran under this section is in 
addition to any other hospital care or medical service furnished by the 
Department for that veteran for post-traumatic stress disorder, and an 
improvement in symptoms as a result of the provision of a service dog 
shall not affect the eligibility of the veteran for any other benefit 
under the laws administered by the Secretary.
    (f) Metrics.--In carrying out this section, the Secretary shall--
            (1) develop metrics and other appropriate means to measure, 
        with respect to veterans participating in the pilot program, 
        the improvement in psychosocial function and therapeutic 
        compliance of such veterans and changes with respect to the 
        dependence on prescription narcotics and psychotropic 
        medication of such veterans; and
            (2) establish processes to document and track the progress 
        of such veterans under the pilot program in terms of the 
        benefits and improvements noted as a result of the pilot 
        program.
    (g) GAO Briefing and Study.--
            (1) Briefing.--Not later than one year after the date on 
        which the Secretary commences the pilot program under 
        subsection (a), the Comptroller General of the United States 
        shall provide to the Committees on Veterans' Affairs of the 
        House of Representatives and the Senate a briefing on the 
        methodology established for the pilot program.
            (2) Report.--Not later than 270 days after the date on 
        which the pilot program terminates, the Comptroller General 
        shall submit to the committees specified in paragraph (1) a 
        report on the pilot program. Such report shall include an 
        evaluation of the approach and methodology used for the pilot 
        program with respect to--
                    (A) helping veterans with severe post-traumatic 
                stress disorder return to civilian life;
                    (B) relevant metrics, including reduction in 
                metrics such as reduction in scores under the post-
                traumatic stress disorder checklist (PCL-5), 
                improvement in psychosocial function, and therapeutic 
                compliance; and
                    (C) reducing the dependence of participants on 
                prescription narcotics and psychotropic medication.
    (h) Authorization of Appropriations.--There is authorized to be 
appropriated for the period of fiscal year 2018 through fiscal year 
2023, $10,000,000 to carry out the pilot program under this section.
    (i) Offset.--The amounts otherwise authorized to be appropriated 
for Department of Veterans Affairs Office of Human Resources and 
Administration for the period of fiscal year 2018 through fiscal year 
2023 shall be reduced by $10,000,000.
    (j) Termination.--The authority to carry out a pilot program under 
this section shall terminate on the date that is five years after the 
date of the enactment of this Act. An eligible veteran in possession of 
a service dog furnished under the pilot program as of the termination 
of the pilot program may keep the service dog after the termination of 
the program for the life of the dog.
Example Output: Puppies Assisting Wounded Servicemembers Act of 2017 or the PAWS Act of 2017 This bill directs the Department of Veterans Affairs (VA) to carry out a five-year pilot program under which it provides grants to eligible nonprofit organizations to provide service dogs to veterans who suffer from post-traumatic stress disorder after completing other evidence-based treatment. An organization that receives a grant shall provide for each participating service dog and veteran:  coverage by a commercially available veterinary health insurance policy, hardware clinically determined to be required by the dog to perform the tasks necessary to assist the veteran, payments for travel expenses to obtain the dog, and  travel expenses required to obtain a replacement service dog.  To be eligible for a grant, an organization must: (1) agree to cover all costs in excess of the grant amount to guarantee such benefits, (2) be certified by Assistance Dogs International, (3) provide one-on-one training for each service dog and recipient for 30 hours or more over 90 days or more, and (4) provide an in-house residential facility or other accommodations nearby in which service dog recipients stay for a minimum of 10 days while receiving at least 30 hours of training.  The VA shall develop metrics to measure the improvement in psychosocial function and therapeutic compliance and changes independence on prescription narcotics and psychotropic medication of veterans participating in the program. The Government Accountability Office must report to Congress on the methodology used for the pilot program.

Example Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Missile Defense Burdensharing Act of 
2001''.

SEC. 2. FINDINGS.

    Congress finds the following:
            (1) The United States has established burdensharing 
        arrangements with Japan, member nations of the North Atlantic 
        Treaty Organization (NATO), and other countries to share the 
        costs of common defense efforts and successfully solicited 
        contributions from several countries to offset costs relating 
        to the Persian Gulf War.
            (2) The President has stated that a missile defense system 
        should be deployed to protect allies and other friendly foreign 
        countries as well as the United States.

SEC. 3. DETERMINATION OF SCOPE OF MISSILE DEFENSE SYSTEM; DESIGNATION 
              OF PROTECTED COUNTRIES.

    (a) Determination Relating to Scope of Missile Defense System.--Not 
later than 120 days after the date of the enactment of this Act, the 
President--
            (1) shall determine whether any missile defense system to 
        be developed by the United States is intended to protect the 
        territory of allied or other friendly foreign countries, in 
        addition to the territory of the United States, from ballistic 
        missile attack; and
            (2) shall prepare and transmit to Congress a report 
        containing the determination of the President under paragraph 
        (1).
    (b) Designation of Protected Countries.--If the President makes a 
determination under subsection (a)(1) that a proposed United States 
missile defense system is intended to protect the territory of allied 
or other friendly foreign countries from ballistic missile attack, the 
President--
            (1) shall designate each allied or other friendly foreign 
        country, with respect to which the system is intended to 
        protect, as a protected country for the purposes of this Act, 
        and shall so notify Congress in writing at least 30 days prior 
        to the designation; and
            (2) shall notify Congress in writing at least 30 days prior 
        to the termination of a designation of a country.
    (c) Additional Requirement With Respect to Termination of 
Designation of Protected Countries.--
            (1) In general.--As part of the notification to Congress 
        with respect to the termination of a designation of a country 
        as a protected country under subsection (b)(2), the President 
        shall include a description of the reasons for the termination, 
        including an assessment of the effect of the termination on the 
        security relations between the country and the United States 
        and on mutual commitments of the United States under bilateral 
        and multilateral security arrangements, such as the North 
        Atlantic Treaty.
            (2) Notification of involved countries.--The President 
        shall transmit to the government of a country with respect to 
        which the President has terminated the designation of the 
        country as a protected country under subsection (b)(2) a copy 
        of the notification to Congress with respect to such 
        termination.

SEC. 4. BURDENSHARING CONTRIBUTIONS BY PROTECTED COUNTRIES.

    (a) Solicitation of Contributions.--The President shall seek 
financial contributions from each protected country designated by the 
President under section 3(b)(1) commensurate with the country's 
proportional share of protection from the United States missile defense 
system.
    (b) Use of Contributions.--Contributions received pursuant to 
subsection (a) shall be used to offset costs incurred by the United 
States for deployment of the missile defense system, including costs 
relating to procurement, construction, operations, and personnel.

SEC. 5. ANNUAL REPORTS.

    (a) Report by Secretary of Defense.--
            (1) In general.--The Secretary of Defense, acting through 
        the Ballistic Missile Defense Organization, shall submit to 
        Congress an annual report that--
                    (A) identifies each foreign country that would 
                receive protection under the missile defense system 
                from ballistic missile attack, irrespective of whether 
                or not the country has been designated by the President 
                under section 3(b)(1) as a protected country; and
                    (B) describes the nature and extent of the 
                protection for each such foreign country.
            (2) Form.--The report shall be submitted in unclassified 
        form, but may contain a classified annex.
    (b) Report by the President.--The President shall transmit to 
Congress as part of the annual budget request a report that--
            (1) describes the extent to which each protected country 
        designated by the President under section 3(b)(1) has provided 
        financial contributions to the United States in accordance with 
        section 4(a);
            (2) describes the proportion of actual and expected 
        contributions by each protected country as a share of overall 
        costs of the missile defense system; and
            (3) describes efforts by the United States to obtain 
        payments from protected countries that have not fully 
        contributed to their share of protection under the missile 
        defense system.

SEC. 6. RULE OF CONSTRUCTION.

    In this Act, the term ``missile defense system'' does not include a 
theater missile defense system that is designed or deployed to defend 
elements of the United States Armed Forces that are deployed outside 
the United States.
Example Output: Missile Defense Burdensharing Act of 2001 - Directs the President to: (1) determine whether any missile defense system to be developed by the United States is intended to protect, in addition to U.S. territory, the territory of allied or other friendly countries from ballistic missile attack; and (2) seek financial contributions from each protected country, if any, commensurate with their proportional share of protection from such system.

Example Input: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Reciprocity Ensures Streamlined Use 
of Lifesaving Treatments Act of 2015''.

SEC. 2. RECIPROCAL MARKETING APPROVAL FOR CERTAIN DRUGS, BIOLOGICAL 
              PRODUCTS, AND DEVICES.

    The Federal Food, Drug, and Cosmetic Act is amended by inserting 
after section 524A of such Act (21 U.S.C. 360n-1) the following:

``SEC. 524B. RECIPROCAL MARKETING APPROVAL.

    ``(a) In General.--A covered product with reciprocal marketing 
approval in effect under this section is deemed to be subject to an 
application or premarket notification for which an approval or 
clearance is in effect under section 505(c), 510(k), or 515 of this Act 
or section 351(a) of the Public Health Service Act, as applicable.
    ``(b) Eligibility.--The Secretary shall, with respect to a covered 
product, grant reciprocal marketing approval if--
            ``(1) the sponsor of the covered product submits a request 
        for reciprocal marketing approval; and
            ``(2) the request demonstrates to the Secretary's 
        satisfaction that--
                    ``(A) the covered product is authorized to be 
                lawfully marketed in one or more of the countries 
                included in the list under section 802(b)(1);
                    ``(B) absent reciprocal marketing approval, the 
                covered product is not approved or cleared for 
                marketing, as described in subsection (a);
                    ``(C) the Secretary has not, because of any concern 
                relating to the safety or effectiveness of the covered 
                product, rescinded or withdrawn any such approval or 
                clearance;
                    ``(D) the authorization to market the covered 
                product in one or more of the countries included in the 
                list under section 802(b)(1) has not, because of any 
                concern relating to the safety or effectiveness of the 
                covered product, been rescinded or withdrawn;
                    ``(E) the covered product is not a banned device 
                under section 516; and
                    ``(F) there is a public health or unmet medical 
                need for the covered product in the United States.
    ``(c) Safety and Effectiveness.--
            ``(1) In general.--The Secretary--
                    ``(A) may decline to grant reciprocal marketing 
                approval under this section with respect to a covered 
                product if the Secretary affirmatively determines that 
                the covered product--
                            ``(i) is a drug that is not safe and 
                        effective; or
                            ``(ii) is a device for which there is no 
                        reasonable assurance of safety and 
                        effectiveness; and
                    ``(B) may condition reciprocal marketing approval 
                under this section on the conduct of specified 
                postmarket studies, which may include such studies 
                pursuant to a risk evaluation and mitigation strategy 
                under section 505-1.
            ``(2) Report to congress.--Upon declining to grant 
        reciprocal marketing approval under this section with respect 
        to a covered product, the Secretary shall--
                    ``(A) include the denial in a list of such denials 
                for each month; and
                    ``(B) not later than the end of the respective 
                month, submit the list to the Committee on Energy and 
                Commerce of the House of Representatives and the 
                Committee on Health, Education, Labor and Pensions of 
                the Senate.
    ``(d) Request.--A request for reciprocal marketing approval shall--
            ``(1) be in such form, be submitted in such manner, and 
        contain such information as the Secretary deems necessary to 
        determine whether the criteria listed in subsection (b)(2) are 
        met; and
            ``(2) include, with respect to each country included in the 
        list under section 802(b)(1) where the covered product is 
        authorized to be lawfully marketed, as described in subsection 
        (b)(2)(A), an English translation of the dossier issued by such 
        country to authorize such marketing.
    ``(e) Timing.--The Secretary shall issue an order granting, or 
declining to grant, reciprocal marketing approval with respect to a 
covered product not later than 30 days after the Secretary's receipt of 
a request under subsection (b)(1) for the product. An order issued 
under this subsection shall take effect subject to Congressional 
disapproval under subsection (g).
    ``(f) Labeling; Device Classification.--During the 30-day period 
described in subsection (e)--
            ``(1) the Secretary and the sponsor of the covered product 
        shall expeditiously negotiate and finalize the form and content 
        of the labeling for a covered product for which reciprocal 
        marketing approval is to be granted; and
            ``(2) in the case of a device for which reciprocal 
        marketing approval is to be granted, the Secretary shall--
                    ``(A) classify the device pursuant to section 513; 
                and
                    ``(B) determine whether, absent reciprocal 
                marketing approval, the device would need to be cleared 
                pursuant to section 510(k) or approved pursuant to 
                section 515 to be lawfully marketed under this Act.
    ``(g) Congressional Disapproval of FDA Orders.--
            ``(1) In general.--A decision of the Secretary to decline 
        to grant reciprocal marketing approval under this section shall 
        not take effect if a joint resolution of disapproval of the 
        decision is enacted.
            ``(2) Procedure.--
                    ``(A) In general.--Subject to subparagraph (B), the 
                procedures described in subsections (b) through (g) of 
                section 802 of title 5, United States Code, shall apply 
                to the consideration of a joint resolution under this 
                subsection.
                    ``(B) Terms.--For purposes of this subsection--
                            ``(i) the reference to `section 801(a)(1)' 
                        in section 802(b)(2)(A) of title 5, United 
                        States Code, shall be considered to refer to 
                        subsection (c)(2); and
                            ``(ii) the reference to `section 
                        801(a)(1)(A)' in section 802(e)(2) of title 5, 
                        United States Code, shall be considered to 
                        refer to subsection (c)(2).
            ``(3) Effect of congressional disapproval.--Reciprocal 
        marketing approval under this section with respect to the 
        applicable covered product shall take effect upon enactment of 
        a joint resolution of disapproval under this subsection.
    ``(h) Applicability of Relevant Provisions.--The provisions of this 
Act shall apply with respect to a covered product for which reciprocal 
marketing approval is in effect to the same extent and in the same 
manner as such provisions apply with respect to a product for which 
approval or clearance of an application or premarket notification under 
section 505(c), 510(k), or 515 of this Act or section 351(a) of the 
Public Health Service Act, as applicable, is in effect.
    ``(i) Fees for Request.--For purposes of imposing fees under 
chapter VII, a request for reciprocal marketing approval under this 
section shall be treated as an application or premarket notification 
for approval or clearance under section 505(c), 510(k), or 515 of this 
Act or section 351(a) of the Public Health Service Act, as applicable.
    ``(j) Outreach.--The Secretary shall conduct an outreach campaign 
to encourage the sponsors of covered products that are potentially 
eligible for reciprocal marketing approval to request such approval.
    ``(k) Covered Product Defined.--In this section, the term `covered 
product' means a drug, biological product, or device.''.
Example Output:
Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2015 This bill amends the Federal Food, Drug, and Cosmetic Act to establish a reciprocal marketing approval process that allows for the sale of a drug, biological product, or medical device that has not been approved by the Food and Drug Administration (FDA) if the product is approved for sale in another country. For a product to be granted reciprocal marketing approval, the product's sponsor must submit a request to the FDA that demonstrates: (1) the product may be sold in at least one country from a specified list of countries, (2) the FDA and listed countries have not withdrawn approval of the product because of safety or effectiveness concerns, and (3) there is a public health or unmet medical need for the product. The FDA may: (1) require postmarket studies of a product granted reciprocal marketing approval, or (2) decline to approve a product that is not safe and effective. The FDA must grant or decline reciprocal marketing approval not later than 30 days after receiving a request. During that period, the FDA and product sponsor must negotiate and finalize product labeling and, for a medical device, classify the device. Congress may pass a joint resolution to grant reciprocal marketing approval to a product that the FDA declines to approve through this process. User fees apply to requests for reciprocal marketing approval. The FDA must encourage the sponsors of potentially eligible products to request reciprocal marketing approval.